Novel Function of NUP153 in HNF4α Transcriptional Upregulation Contributes to Promoting HBV Replication
- 27 February 2025
- journal article
- Published by Wiley in Journal of Medical Virology
- Vol. 97 (3) , e70256
Abstract
Hepatitis B virus (HBV) infection remains a major public health problem, causing nearly one million deaths annually. Nucleoporin 153 (NUP153) is known to facilitate the nuclear entry of the human immunodeficiency virus (HIV) nucleocapsids, and recent studies suggest it also plays a role in HBV nucleocapsids nuclear import. We aimed to investigate the impact of NUP153 on HBV replication and its underlying mechanism. NUP153 was knocked down by RNA interference or CRISPR/Cas9‐mediated gene disruption, or overexpressed using an expression plasmid in HBV‐replicating cells and animal model. Luciferase reporter assays were employed to assess the activities of viral or host factor promoters. Cytoplasmic and nuclear fractionation experiments were conducted to analyze the subcellular distribution of proteins and HBV RNA. In the present study, we found that knockdown of NUP153 significantly inhibited HBV replication without affecting the levels of covalently closed circular DNA (cccDNA) in both the prcccDNA/Cre recombinant plasmid system and HepG2‐NTCP cells. Consistent results were observed in a mouse model hydrodynamically injected (HDI) with 1.2 × HBV plasmid. Conversely, NUP153 overexpression markedly increased cccDNA transcription and progeny virus production. Further study revealed that NUP153 enhanced HBV core promoter activity, likely through a hepatocyte nuclear factor 4α (HNF4α)‐dependent mechanism. Mechanistically, ERK signaling was essential for NUP153‐mediated promotion of HNF4α and HBV replication. Additionally, HBV replication significantly upregulated NUP153 mRNA and protein levels in both HBV cell models and HBV‐infected patients. Together, we identify NUP153 as a novel host factor that promotes HBV replication by enhancing cccDNA transcription through the upregulation of HNF4α, suggesting a potential therapeutic strategy for HBV replication.Keywords
Funding Information
- National Natural Science Foundation of China
This publication has 36 references indexed in Scilit:
- Discovery and mechanistic study of Imperatorin that inhibits HBsAg expression and cccDNA transcriptionJournal of Medical Virology, 2024
- Chromatin binding protein HMGN1 promotes HBV cccDNA transcription and replication by regulating the phosphorylation of histone 3Antiviral Research, 2024
- Deubiquitinase OTUD5 promotes hepatitis B virus replication by removing K48-linked ubiquitination of HBV core/precore and upregulates HNF4ɑ expressions by inhibiting the ERK1/2/mitogen-activated protein kinase pathwayCellular and Molecular Life Sciences, 2023
- NUP153 promotes HCC cells proliferation via c-Myc-mediated downregulation of P15INK4bDigestive and Liver Disease, 2022
- HBV Genome and Life Cycle2019
- FoxO4 inhibits HBV core promoter activity through ERK-mediated downregulation of HNF4αAntiviral Research, 2019
- Hepatitis B virus genome recycling and de novo secondary infection events maintain stable cccDNA levelsJournal of Hepatology, 2018
- Recombinant covalently closed circular DNA of hepatitis B virus induces long‐term viral persistence with chronic hepatitis in a mouse modelHepatology, 2017
- Hepatitis B virus e antigen production is dependent upon covalently closed circular (ccc) DNA in HepAD38 cell cultures and may serve as a cccDNA surrogate in antiviral screening assaysAntiviral Research, 2006
- Versatility at the nuclear pore complex: lessons learned from the nucleoporin Nup153Chromosoma, 2005